SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-20-019010
Filing Date
2020-10-06
Accepted
2020-10-06 15:18:29
Documents
1
Period of Report
2020-09-25

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1564
  Complete submission text file 0001493152-20-019010.txt   3008
Mailing Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452
Business Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452 (201) 444-4947
RespireRx Pharmaceuticals Inc. (Issuer) CIK: 0000849636 (see all company filings)

IRS No.: 330303583 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452
Business Address
Dickason David (Reporting) CIK: 0001827349 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-16467 | Film No.: 201226602